2014
DOI: 10.1200/jco.2014.32.15_suppl.3079
|View full text |Cite
|
Sign up to set email alerts
|

Rapid cell expansion (RACE) technology for production of engineered autologous T-cell therapy: Path toward manageable multicenter clinical trials in aggressive NHL with anti-CD19 CAR.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles